The company Geron on Wednesday announced that it has received oral notice from FDA that the agency is delaying a decision on the company's application for the first clinical trial using human embryonic stem cells in humans, Bloomberg/New York Times reports.
[read full story]
Research from the University of Southern California (USC) has discovered a new mechanism to allow embryonic stem cells to divide indefinitely and remain undifferentiated. The study, which is published in the May 22 issue of the journal Nature, also reveals how embryonic stem cell multiplication...
Research discovers method to duplicate primitive stem cells and prevent cell differentiation Research from the University of Southern California (USC) has discovered a new mechanism to allow embryonic stem cells to divide indefinitely and remain undifferentiated. "Our study suggests that what we...
From Townhall.com WASHINGTON (BP)–The U.S. Food and Drug Administration has put a hold on proposed clinical trials using embryonic stem cells in human beings. The news was a blow to the hopes of the Geron Corp., which had applied for FDA approval for the first such experiments. The...